Literature DB >> 23268729

Effects of acute intrathecal baclofen in an animal model of TBI-induced spasticity, cognitive, and balance disabilities.

Prodip Bose1, Jiamei Hou, Rachel Nelson, Nicole Nissim, Ron Parmer, Jonathon Keener, Paul W Wacnik, Floyd J Thompson.   

Abstract

Spasticity is a major health problem for patients with traumatic brain injury (TBI). In addition to spasticity, TBI patients exhibit enduring cognitive, balance, and other motor impairments. Although the use of antispastic medications, particularly ITB, can decrease the severity of TBI-induced spasticity, current guidelines preclude the use of ITB during the first year after TBI. Therefore, the present study was performed to quantitate disability in an animal model of closed-head TBI (cTBI; Mararou's model) after ITB treatment. After cTBI, significant deficits in spasticity and gait, cognitive, balance, and anxiety-like behaviors were detected. ITB (Lioresal(®)) or saline was administered using Alzet pumps (0.8 μg/hour for 4 weeks). Spasticity measures using velocity-dependent ankle torque and ankle extensor muscle electromyography recordings, footprints (gait), balance performance tests, serial learning, and anxiety-like behaviors were performed at multiple post-treatment and -withdrawal of ITB time points. Our data indicated that 1 month of ITB treatment initiated at post-TBI week 1 blocked the early onset of spasticity and significantly attenuated late-onset spasticity and anxiety-like behavior with no significant adverse effects on cognitive and balance performance. This improved spasticity outcome was accompanied by marked up-regulation of gamma-aminobutyric acid (GABA)/GABAb, norepinephrine, and brain-derived neurotrophic factor expression in spinal cord tissue. Early intervention with ITB treatment was safe, feasible, and effective in this cTBI animal model. Collectively, these data provide a strong molecular footprint of enhanced expression of reflex regulation by presynaptic inhibition. The possibility that acute ITB treatment may decrease maladaptive segmental and descending plasticity is discussed. The data provided by the present animal model initiates a pre-clinical platform for safety, feasibility, and efficacy of early ITB intervention after TBI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23268729     DOI: 10.1089/neu.2012.2740

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  8 in total

Review 1.  Preclinical models of muscle spasticity: valuable tools in the development of novel treatment for neurological diseases and conditions.

Authors:  Anton Bespalov; Liudmila Mus; Edwin Zvartau
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02-10       Impact factor: 3.000

2.  Trigeminal neuroplasticity underlies allodynia in a preclinical model of mild closed head traumatic brain injury (cTBI).

Authors:  Golam Mustafa; Jiamei Hou; Shigeharu Tsuda; Rachel Nelson; Ankita Sinharoy; Zachary Wilkie; Rahul Pandey; Robert M Caudle; John K Neubert; Floyd J Thompson; Prodip Bose
Journal:  Neuropharmacology       Date:  2016-03-10       Impact factor: 5.250

3.  A Novel Closed-Head Model of Mild Traumatic Brain Injury Using Focal Primary Overpressure Blast to the Cranium in Mice.

Authors:  Natalie H Guley; Joshua T Rogers; Nobel A Del Mar; Yunping Deng; Rafiqul M Islam; Lauren D'Surney; Jessica Ferrell; Bowei Deng; Jessica Hines-Beard; Wei Bu; Huiling Ren; Andrea J Elberger; Jeffrey G Marchetta; Tonia S Rex; Marcia G Honig; Anton Reiner
Journal:  J Neurotrauma       Date:  2015-12-17       Impact factor: 5.269

4.  The Chemokine Receptor CXCR2 Supports Nociceptive Sensitization after Traumatic Brain Injury.

Authors:  De-Yong Liang; Xiaoyou Shi; Peng Liu; Yuan Sun; Peyman Sahbaie; Wen-Wu Li; David C Yeomans; J David Clark
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

5.  Focal traumatic brain injury induces neuroplastic molecular responses in lumbar spinal cord.

Authors:  Olga Kononenko; Hiroyuki Watanabe; Lada Stålhandske; Ann Zarelius; Fredrik Clausen; Tatiana Yakovleva; Georgy Bakalkin; Niklas Marklund
Journal:  Restor Neurol Neurosci       Date:  2019       Impact factor: 2.406

Review 6.  Management of Spasticity After Traumatic Brain Injury in Children.

Authors:  Johannes M N Enslin; Ursula K Rohlwink; Anthony Figaji
Journal:  Front Neurol       Date:  2020-02-21       Impact factor: 4.003

7.  A novel closed-head model of mild traumatic brain injury caused by primary overpressure blast to the cranium produces sustained emotional deficits in mice.

Authors:  Scott A Heldt; Andrea J Elberger; Yunping Deng; Natalie H Guley; Nobel Del Mar; Joshua Rogers; Gy Won Choi; Jessica Ferrell; Tonia S Rex; Marcia G Honig; Anton Reiner
Journal:  Front Neurol       Date:  2014-01-22       Impact factor: 4.003

8.  Mild closed head traumatic brain injury-induced changes in monoamine neurotransmitters in the trigeminal subnuclei of a rat model: mechanisms underlying orofacial allodynias and headache.

Authors:  Golam Mustafa; Jiamei Hou; Rachel Nelson; Shigeharu Tsuda; Mansura Jahan; Naweed S Mohammad; Joseph V Watts; Floyd J Thompson; Prodip Bose
Journal:  Neural Regen Res       Date:  2017-06       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.